Dihydrolipoic acid as ophthalmological agent to suppress intolerable reactions in the aea between implants and living body tissue.

摘要

PCT No. PCT/EP94/01110 Sec. 371 Date Mar. 15, 1996 Sec. 102(e) Date Mar. 15, 1996 PCT Filed Apr. 11, 1994 PCT Pub. No. WO94/27592 PCT Pub. Date Dec. 8, 1994Pharmaceutical compositions comprising dihydrolipoic acid or physiologically acceptable salts thereof are disclosed for the treatment of eye diseases and intolerance reactions in the area between implants and endoprostheses, in particular ophthalmological implants and endoprostheses with living body tissue.